Literature DB >> 11694267

Alterations in myocardial lipid metabolism during myocardial ischemia and reperfusion.

David A Ford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11694267     DOI： 10.1016/s0163-7827(01)00014-5

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN： 0163-7827            Impact factor:   16.195


× No keyword cloud information.
  9 in total

1.  MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation model.

Authors:  Robert F Menger; Whitney L Stutts; Dhanalakshmi S Anbukumar; John A Bowden; David A Ford; Richard A Yost
Journal:  Anal Chem       Date:  2011-12-22       Impact factor: 6.986

2.  Short term administration of L-carnitine can be detrimental to the ischemic heart.

Authors:  Moslem Najafi; Alireza Garjani
Journal:  Adv Pharm Bull       Date:  2013-12-23

Review 3.  Energy substrate metabolism in cardiac hypertrophy.

Authors:  Michael F Allard
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

4.  Effects of hypoxia, glucose deprivation and acidosis on phosphatidylcholine synthesis in HL-1 cardiomyocytes. CTP:phosphocholine cytidylyltransferase activity correlates with sarcolemmal disruption.

Authors:  Elisabet Sarri; David Garcia-Dorado; Arancha Abellan; Jordi Soler-Soler
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

5.  Suppression of calcium sparks in rat ventricular myocytes and direct inhibition of sheep cardiac RyR channels by EPA, DHA and oleic acid.

Authors:  B N Honen; D A Saint; D R Laver
Journal:  J Membr Biol       Date:  2003-11-15       Impact factor: 1.843

6.  Acute administration of natural honey protects isolated heart in normothermic ischemia.

Authors:  Afshin Gharekhani; Moslem Najafi; Hamed Ghavimi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

7.  Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction.

Authors:  Ting-Ting Tang; Yuan-Yuan Li; Jing-Jing Li; Ke Wang; Yue Han; Wen-Yong Dong; Zheng-Feng Zhu; Ni Xia; Shao-Fang Nie; Min Zhang; Zhi-Peng Zeng; Bing-Jie Lv; Jiao Jiao; Heng Liu; Zong-Shu Xian; Xiang-Ping Yang; Yu Hu; Yu-Hua Liao; Qing Wang; Xin Tu; Ziad Mallat; Yu Huang; Guo-Ping Shi; Xiang Cheng
Journal:  Theranostics       Date:  2018-08-10       Impact factor: 11.556

8.  Xin-Ji-Er-Kang protects heart from ischemia-reperfusion injury by rebalancing lipid metabolism.

Authors:  Li-Jun Sun; Xiao-Yu Wang; Jie Xia; Yan-Mei Xu; Yu-Feng Liao; Yuan-Yuan Qin; Xue-Wan Ge; Pei-Wen Zhao; Tong Xu; Xiao-Ling Zhu; Shan Gao; Rui Xiao; Xue-Sheng Liu; Kai Zhou
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

9.  Optimization of 5' Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury.

Authors:  Nishat Sultana; Yoav Hadas; Mohammad Tofael Kabir Sharkar; Keerat Kaur; Ajit Magadum; Ann Anu Kurian; Nadia Hossain; Bremy Alburquerque; Sakib Ahmed; Elena Chepurko; Lior Zangi
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-31       Impact factor: 5.849
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.